Repeated TACE in HCC after Fontan surgery and situs viscerum inversus: A case report.
Radiol Case Rep
; 16(9): 2564-2569, 2021 Sep.
Article
en En
| MEDLINE
| ID: mdl-34306288
We describe the case of a 32-year-old man who developed a liver neoplasm due to previous Fontan surgery (FS) for a single ventricle anomaly and situs viscerum inversus. He was admitted to our hospital for suspected hepatocellular carcinoma during an Ultrasound (US) follow up. Computed tomography (CT) showed features of chronic liver disease and 7 cm hepatic nodule with arterial enhancement. Laboratory analyses documented preserved liver function and increased levels of alpha-fetoprotein. Trans-arterial-chemoembolization (TACE) was performed obtaining complete necrosis at 4 weeks of follow up and significant reduction of alpha-fetoprotein. The patient is currently in follow-up, being evaluated for further treatments and/or combined liver-heart transplantation. TACE is a therapeutic option for the treatment of patients with unresectable hepatocellular carcinoma (HCC) and with severe heart disease, like those submitted to FS and with also other vascular abnormalities like those correlated to situs viscerum inversus.
CM, Contrast Medium; CT, Computed Tomography, EDVi, End- Diastolic Volume index, EF, Ejection Fraction; Cardiac cirrhosis; Congenital heart disease; FALD, Fontan-associated liver disease; Fontan surgery; HCC, hepatocellular carcinoma; HR, Heart Rate; IVC-PA, Inferior Vena Cava-Pulmonary Artery; MRI, Magnetic Resonance Imaging; SI, Situs inversus; SMA, Superior Mesenteric Artery; Situs viscerum inversus; TACE, Trans Arterial ChemoEmbolization; TACE, trans-arterial-chemoembolization; US, Ultrasound; bpm, beats per minute; ceCT, Contrast Enhanced CT; ceCT, contrast enhanced Computed Tomography
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Radiol Case Rep
Año:
2021
Tipo del documento:
Article
País de afiliación:
Italia
Pais de publicación:
Países Bajos